Vanda Pharmaceuticals (VNDA) Shares Outstanding (Weighted Average) (2009 - 2026)

Vanda Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $59.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.59% year-over-year to $59.5 million; the TTM figure through Mar 2026 stood at $59.5 million (up 1.59% YoY), while the FY2025 annual figure was $58.9 million, up 1.34% from the prior year.
• Shares Outstanding (Weighted Average) came in at $59.5 million for Q1 2026 at Vanda Pharmaceuticals, up from $58.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $59.5 million in Q1 2026 to a low of $56.1 million in Q1 2022.
• A 5-year average of $57.8 million and a median of $57.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) advanced 2.04% in 2023 and rose 1.31% in 2024, its largest moves.
• Vanda Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $56.5 million in 2022, then climbed by 1.63% to $57.4 million in 2023, then grew by 1.34% to $58.1 million in 2024, then gained by 1.34% to $58.9 million in 2025, then advanced by 0.9% to $59.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $59.5 million, $58.9 million, and $59.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison